Core Viewpoint - Fortrea Holdings Inc. is facing a federal securities class action lawsuit due to allegations of misleading statements regarding its financial performance and business model, particularly concerning its revenue projections and cost savings [5][3]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi, LLP is investigating potential claims against Fortrea and has set an August 1, 2025 deadline for investors to seek the role of lead plaintiff in the class action [3]. - Investors who suffered losses exceeding $50,000 in Fortrea between July 3, 2023, and February 28, 2025, are encouraged to contact the firm for legal options [1]. Group 2: Allegations Against Fortrea - The complaint alleges that Fortrea overestimated revenue contributions from Pre-Spin Projects and overstated cost savings from exiting Transition Service Agreements (TSAs), leading to inflated EBITDA targets for 2025 [5]. - The company's public statements regarding its business model and financial prospects were deemed materially false and misleading [5]. Group 3: Stock Performance and Analyst Downgrades - On September 25, 2024, Jefferies downgraded Fortrea from buy to hold, citing weaknesses in its business model and a decline in stock price by $2.73 (12.29%) to $19.48 [6]. - Following the cancellation of two scheduled conferences, Baird Equity Research downgraded Fortrea to neutral on December 6, 2024, resulting in a stock price drop of $1.90 (8.06%) to $21.67 [7]. - Fortrea's fourth quarter and full year 2024 results revealed that its revenue and adjusted EBITDA expectations for 2025 were not aligned with prior forecasts, causing a significant stock price decline of $3.47 (25.05%) to $10.38 on March 3, 2025 [8].

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, following allegations of overstating cost savings and revenue projections related to transition services agreements after its spin-off from Labcorp [1][2][4]. Group 1: Company Background - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Fortrea exaggerated the cost savings and margin improvements expected from exiting transition services agreements with Labcorp, as well as the revenue from pre-spin projects [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing Q4 and full-year 2024 financial results, revealing lower-than-expected revenue and profitability from pre-spin projects, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, specifically related to the company's financial disclosures and performance claims [1][2]. Company Overview - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 and entered into transition services agreements with Labcorp [3]. Allegations - The lawsuit alleges that Fortrea overstated the cost savings and margin improvements expected from exiting the transition services agreements, as well as the revenue from pre-spin projects [4]. Stock Performance - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 [5]. - On March 3, 2025, Fortrea announced disappointing financial results for Q4 and the full year 2024, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 [6].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Fortrea To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Fortrea between July 3, 2023 and February 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 20, 2025 /PRNewswire/ ...

clarity. >> Well likely Mike thanks. Mike Santoli.Now let's bring in David Zervos of Jefferies who's hoping for a more dovish fed this week. David do you think we're going to get one. >> You know I think John they're going to they're going to spin a dovish or at least in the press conference I think there's a little dovishness the narrative that Chair Powell has pushed forward kind of hasn't played out.Or the worst case scenario of what he was worried about hasn't played out. We've seen the inflation data c ...

Group 1 - The geopolitical tensions in the Middle East have led to rising oil prices, raising inflation concerns and putting pressure on the US and European bond markets [1][8] - The US 2-year Treasury yield rose by 2 basis points to 3.96%, while the 10-year Treasury yield increased by 3 basis points to 4.43%, underperforming compared to German bonds [2][5] - The yield curve for US Treasuries has steepened, indicating market expectations of higher future inflation and interest rates, with the 2-year yield increasing by 8 basis points since last Thursday, lower than the increase in the 10-year yield [5][6] Group 2 - Analysts suggest that the US Treasury yield curve may continue to steepen due to increased geopolitical uncertainty, which could raise future military spending and make inflation more persistent if oil prices remain high [6][8] - Since the escalation of tensions between Israel and Iran, the benchmark US Treasury yield has risen by 9 basis points, reflecting historical patterns where similar conflicts have led to increased yields [7] - Investors are facing dual risks: inflation concerns stemming from trade tensions and worsening US debt issues, which may require higher risk premiums for holding US Treasuries, leading to sustained upward pressure on yields [8]

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, alleging that the company overstated cost savings and revenue projections related to its transition services agreements with Labcorp [1][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, titled Deslande v. Fortrea Holdings Inc., et al., No. 1:25-cv-04630, and investors have until August 1, 2025, to seek lead plaintiff status [2]. - The claims are based on Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, representing investors who purchased Fortrea securities [2]. Group 2: Company Background - Fortrea is a global contract research organization that was spun off from Labcorp Holdings Inc. in June 2023, becoming a standalone publicly traded company [3]. - As part of the spin-off, Fortrea entered into transition services agreements (TSAs) with Labcorp, agreeing to pay for certain transitional services over a specified period [3]. Group 3: Allegations and Stock Performance - Allegations state that Fortrea exaggerated the cost savings and margin improvements expected from exiting the TSAs, as well as the revenue from pre-spin projects [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as claimed, Fortrea's stock fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing Q4 and full-year 2024 results, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

Geopolitical Risk Assessment - Market participants are attempting geopolitical analysis, but accuracy is limited due to uncertainty surrounding Iran-Israel tensions [1][2] - Despite direct missile exchanges between Iran and Israel, the market showed resilience, with only a slight dip [2][3] Market Reaction & Positioning - The market's reaction to geopolitical events was not significantly negative, suggesting potential opportunities in fixed income [4][5] - The market's lack of strong reaction indicates that risk asset positioning is not overly committed [8] - There was an emotional liquidation of US risk asset positioning during April and May, setting the stage for a potential market recovery [6] Economic Factors & Outlook - The market may be underestimating the positives from deregulation, fiscal policy, and trade negotiations [7][8] - A fiscal bill with pro-growth features is expected to pass [8]

Core Viewpoint - Compass Diversified is facing significant challenges due to an accounting scandal at its subsidiary Lugano, leading to a stock downgrade and a class action lawsuit from investors, resulting in a loss of over 70% of its market value in three months [1][3][4]. Group 1: Stock Performance and Analyst Actions - Jefferies analysts downgraded Compass Diversified's stock from Buy to Hold due to a deepening investigation into accounting irregularities at Lugano Holdings [2][3]. - The price target for Compass's stock was slashed from $28.00 to $7.30, reflecting zero value assigned to Lugano amid expectations of a prolonged recovery [3]. Group 2: Legal and Regulatory Challenges - A securities class action lawsuit has been filed against Compass, alleging that the company misled investors regarding accounting issues at Lugano, affecting financial statements for 2024 [6][8]. - S&P Global Ratings downgraded Compass's credit rating to 'B-' and placed it on CreditWatch with negative implications due to unreliable financial statements [4]. Group 3: Company Response and Leadership Changes - In response to the crisis, Compass has entered a forbearance agreement with lenders, suspended quarterly distributions, and halted further investments in Lugano [5]. - Leadership changes occurred with Josh Gaynor appointed as interim CEO following the resignation of Lugano's founder, Moti Ferder [5]. Group 4: Historical Context and Future Implications - The acquisition of Lugano in 2021, valued at $256 million, is now viewed as risky due to alleged failures in internal controls that left investors exposed to hidden liabilities [7].